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Non-traditional/non-classical/non-Mendelian patterns of
inheritance refer to different modes of transmission of genetic
diseases that are not caused by single mutant genes. These dis-
eases include a wide variety of genetically-determined disor-
ders, e.g., polygenic diseases/chromosomal aberrations/
mitochondrial disorders and multifactorial diseases. Non-tra-
ditional inheritance patterns are not compatible with the rules
of inheritance that characterize the transmission of single gene
disorders since they differ from each other in many respects
like rates of occurrence, recurrence risk, sex predilection, spec-
trum of phenotypic variation and many others. The character-
istics of these non-traditional patterns are dependent solely on
the nature of the disease as regards its etiology and the specific
pathogenetic mechanism(s) underlying its development.
Recognition of these different inheritance patterns is impor-
tant for the provision of proper counseling advice because they
have different recurrence risks and different clinical and man-
agement implications. Non-traditional patterns of inheritance
characterize diseases caused by specific pathogenetic mecha-
nisms that include: defective genetic imprinting, uniparental
disomy, nucleotide repeat expansion (tri/tetra/penta/
hexa-nucleotide repeat expansion), mutations of mitochon-
drial genome, mutations caused by combined multifactorial
(genetic/environmental) effects, mosaicism, chromosomal
aberrations, microdeletion/microduplication/microtriplication
defects and polygenic defects [1] (Table 1).1. Genetic imprinting
Genetic imprinting refers to the predetermined functional sta-
tus of a gene, a group of genes, part or most of a chromosome.
This imprint might be imposed by different factors. For
instance, it might be imposed by the parental origin, i.e. spe-
cific genes or sets of genes transmitted by the mother or the
father may be expressed or suppressed according to their par-
ent of origin, thus resulting in a specific monoallelic gene
expression profile. This type of imprinting might be referred
to as parental imprinting [2]. Alternatively, a gene might be
silenced/suppressed/turned off or kept functioning following
the completion of the critical stages of embryogenesis/differen-
tiation/growth and development of the offspring. This type of
imprinting might be referred to as temporal imprinting. A third
type of imprinting that might be referred to as spatial imprint-
ing is determined by the location of the gene, where a gene is
suppressed or activated by regulatory mechanisms imposed
by adjacent chromatin modifications (Table 2).
In diploid organisms, somatic cells possess two copies of the
genome and each autosomal gene is represented by two copies,
or alleles, with one copy inherited from each parent at fertiliza-
tion. For the vast majority of autosomal genes, expression
occurs from both alleles simultaneously. In mammals, how-
ever, a small proportion (<1%) of genes are parentally
imprinted, meaning that gene expression occurs from only
one allele. The expressed allele is dependent upon its parental
origin. For example, the gene encoding Insulin-like growth fac-
tor 2 (IGF2/Igf2) is only expressed from the allele inherited
from the father [3].
Imprinting is a fundamental genomic regulatory mechanism
during development and differentiation whereby overexpres-
sion of specific sets of maternal or paternal genes and silencing
of other sets of maternal or paternal genes is mandatory for
Table 1 Pathogenetic mechanisms underlying non-traditional
inheritance patterns.
1. Defective genetic imprinting
2. Uniparental disomy
3. Nucleotide repeat expansion (tri/tetra/penta/hexa-nucleotide
repeat expansion)
4. Mutations of mitochondrial genome






410 M.S.Z. Salemensuring proper growth, differentiation and specialization of
embryonic and fetal tissues and organs. This specific pattern
of genetic imprinting inherited from both parents is maintained
in somatic cells of the offspring all through the postnatal life.
However, if genomic regulation over this default specific expres-
sion/suppression profile is lost or disturbed due to mutational
events, defective imprinting results. Suppression or silencing
of maternal or paternal genes that are normally active in their
normal condition will result in functional deficiency of their
product(s). Similarly, overexpression of genes that are kept
silenced after differentiation and specialization, or that function
within their programed scale, will result in re-transcription/re-
synthesis of their products. In either condition, perturbation
of the strict functional balance between the three major compo-
nents of the genetic material of the cell, the genome/the tran-
scriptome/the proteome, occurs leading to the development of
imprinting defects and pathogenesis of imprinting disorders.
The exact pathogenetic mechanisms underlying the develop-
ment of imprinting defects are neither clear nor completely
understood up till now, though many epigenetic alterations of
the genome, including methylation/demethylation of DNA
and chromatin modifications have been proposed as factors
implicated in imprinting. Pathogenesis of genetic disorders
due to imprinting happen when individuals having suppressed
or silenced imprinted genes, thus behaving like functional car-
riers or heterozygotes, develop mutational defect of the other
normal allele thus turning them into diseased homozygotes.Table 2 Imprinting disorders.
Disorder Pathogenetic mechanism
Prader–Willi syndrome Paternal inheritance of th
long arm of chromosome
Angelman syndrome Maternal inheritance of t
long arm of chromosome
Beckwith–Wiedemann syndrome 1. overactivity of the IGF-
2. Suppressed or deleted c
(inhibitor of cell prolifera
3. KCNQ1OT1KCNQ1 g
syndrome due to 11p15 mi





1. Unipaternal disomy of
2. Imprinting of genes on
Ovarian and breast cancers
(41% of cases)
Loss of the expression ofOn the other hand, large numbers of genes are known to con-
trol and regulate different aspects of post-fertilization processes
and promote the exceedingly accelerated rates of growth and
proliferation of embryonic and fetal cells. As the need for these
genes diminishes markedly after that period, these genes are
turned off and kept suppressed. Defects in maintaining the sup-
pressed imprinting status of these genes leading to their reacti-
vation might offer another plausible hypothesis to explain
pathogenetic mechanisms underlying the development of
genetic diseases resulting because of overexpression of tempo-
rally suppressed imprinted genes, like cancer.
In parental imprinting, a gene behaves differently depending
on whether it is inherited from the father or from the mother.
Genomic imprinting occurs when a gene or chromosome con-
tributed by the mother differs functionally from a structurally
identical gene or chromosome contributed by the father. There
are a number of human disorders in which the clinical manifes-
tations depend on the sex of the transmitting parent. For
instance, the severe congenital form of myotonic dystrophy is
maternally transmitted and nearly 10–20% of her offspring
who inherit the disorder will manifest this severe form. In the
Prader–Willi syndrome, a gene product needed for normal
development, normally expressed only by the paternal allele, is
missing. The disease phenotype results because the maternal
allele of the gene is normally suppressed, thus affected offspring
behaves like homozygous affected individuals. Approximately,
60–65% of individuals with the Prader–Willi syndrome are
missing the gene due to its deletion from the paternal chromo-
some number 15. Additionally, unimaternal disomy for chro-
mosome number 15, in which the child inherits both copies of
chromosome number 15 from their mother and none from the
father, account for about 30%of the cases. The reverse situation
is met with in the Angelman syndrome caused by similar patho-
geneticmechanisms leading to the functional absence of the gene
when it is inherited from the mother, where the disease pheno-
type results because the paternal allele of the gene is normally
suppressed.
2. Uniparental disomy (UPD)
Uniparental disomy is a rare cytogenetic abnormality. It occurs
when both copies of a chromosome, or parts of a chromosome,e deletion of the chromosomal region 15q11-13 (band 11 of the
15) containing the paternally expressed genes (SNRPN and NDN)
he deletion of the chromosomal region 15q11-13 (band 11 of the
15) containing the paternally expressed genes (SNRPN and NDN)
2 gene (growth factor) on the short arm of chromosome 11, 11p15
opy of CDKN1C Cyclin-dependent kinase inhibitor 1C gene
tion)
ene; overlapping transcript 1 causing the Beckwith–Wiedemann
crodeletion
and IGF2 genes
my (UPD) of chromosome 7
gene(s) on chromosome 7
chromosome 6
the tumor suppressor gene NOEY2 [51
Basic concepts of medical genetics 411are derived from one parent only. There is a preponderance of
maternal versus paternal UPD; approximately 3:1. This rare
event might be caused by different pathogenetic mechanisms
happening during the formation of egg or sperm cells or during
early stages of development. A disomic germ cell, sperm or
ovum, with two allelic chromosomes resulting due to faulty mei-
otic nondisjunction, might participate in fertilization followed
by loss of the allelic chromosome from the other germ cell, thus
leading to the formation of a zygote with two allelic
chromosomes transmitted from one parent only. This mecha-
nism is thought to be the major cause of this cytogenetic abnor-
mality. If nondisjunction affects a chromosome carrying a
recessive mutant gene, the resulting disomic germ cell will have
two chromosomes with two mutant genes. If the normal allelic
chromosome from the other parent is lost in the immediate
post-fertilization division, the zygote will have two mutant
homozygous genes leading to the development of a recessive
genetic disease.Alternatively, if one of themutant chromosomes
is lost, the resulting offspring will develop as a carrier or a het-
erozygote individual with no clinical consequences. Other less
common, rare causes can lead to uniparental disomy, e.g., dupli-
cation of chromosomes or mitotic nondisjunction with selective
loss of the other allelic chromosome in the immediate postfertil-
ization stages. Uniparental disomy occurring late after fertiliza-
tion might result in mosaicism in the placenta or even in parts of
fetal tissues. The clinical phenotype of genetic diseases resulting
from uniparental disomy varies widely depending upon the
parental source of the disomic chromosomes, like the case in
Prader–Willi and Angelman syndromes.
There are different cytogenetic types of uniparental diso-
mies: 1.Heterodisomy in which a pair of non-identical chromo-
somes is inherited from one parent due to an error in earlier
stages meiosis I during germ cell formation. 2. Isodisomy in
which a single chromosome from one parent is duplicated
due to an error in later stages meiosis II or due to postzygotic
chromosomal duplication. Heterodisomy is essentially a
benign condition and cases having it do not suffer phenotypi-
cal anomalies. On the other hand, if isodisomy affects a chro-
mosome carrying a mutant gene from a carrier parent, the
resulting offspring will manifest a recessive genetic disease,
although one of the parents is normal. Accordingly, UPD
should be suspected in cases manifesting recessive disorders,
where only one parent is a carrier. An unexpected inheritance
pattern where a couple of a normal parent and a homozygous
affected parent gets normal offspring, due to unipaternal dis-
omy of the chromosome carrying the gene in question, should
also raise the suspicion of this cytogenetic error. Other aber-
rant inheritance situations that might result from uniparental
disomy include homozygosity of autosomal recessive gene
mutations, homozygosity of X-chromosomal disorders in
females and father-to-son transmission of X-linked traits.
Another potentially hazardous pathogenetic consequence
due to UPD resulting in phenotypical anomalies can be caused
by uniparental inheritance of imprinted genes. If the disomic
chromosomes happen to carry the mutant gene, then the
affected offspring will behave as a homozygous individual and
will have a genetic disease due to the total absence of gene prod-
uct(s). Clinical phenotypes amenable for interpretation by these
mechanisms include: the Prader–Willi syndrome and the Angel-
man syndrome that can be caused by UPD, or other errors in
imprinting, involving genes on the long arm of chromosome15 and the Beckwith–Wiedemann syndrome due to UPD of
imprinted genes on the short arm of chromosome 11.
Apeculiar cytogenetic abnormality caused by the inheritance
of all chromosomes from one parent only is referred to as unipa-
rental diploidy. Several pathogenetic mechanisms might cause
this exceptional cytogenetic error including fertilization of an
ovum by two sperms, post-fertilization duplication of a single
sperm genome with selective exclusion of the genome of the
ovum, total exclusion of sperm genome and duplication of the
genome of the ovum or amalgamation of the genome of both
the ovum and the polar body. These rare events represent
instances of whole genomic imprinting where the whole mater-
nal or paternal genome gets suppressed. These rare abnormali-
ties are incompatible with normal developments, rather they
lead to the formation of defective fertilization outcomes like
hydatidiform moles, dermoid cysts and choriocarcinoma.3. Nucleotide repeat expansion
Abnormal expansion of varying numbers of adjacent nucleo-
tides of a functional gene, upon duplication of the gene during
the DNA replication stage of the cell cycle, is a specific type of
mutational events that lead to the construction of an abnor-
mally large number of nucleotide repeats within the newly rep-
licating gene. The gene becomes structurally abnormal, and if
these expansion defects affect critical segments of the gene,
deficient synthesis of gene products; mRNA/microRNA or
proteins, or synthesis of abnormal defective/unstable gene
products happen leading to the pathogenesis of genetic disor-
ders. Nucleotide repeats normally exist along most genes in
predefined numbers. Defective expansions and abnormal
increase in these numbers disrupt the structural integrity of
the gene and result in consequent functional deterioration
due to resulting defects in synthesis of the gene product(s).
Nucleotide repeat expansion can involve varying numbers
of adjacent nucleotides, e.g., di-, tri-, tetra-, penta- and hexa-
nucleotide repeat expansion. Many molecular mechanisms
have been postulated to be implicated in the pathogenesis of
this specific mutation including defective DNA replication,
fragment ligation and proofreading errors. Uncommon struc-
tural configurations of DNA during replication might also pre-
dispose to this pathogenetic defect [4].
Nucleotide repeat expansion is characterized by a progres-
sive attitude. As the condition passes from one generation to
the next in a given family, the repeat sequence is amplified
causing more structural damage and more functional deterio-
ration of the gene, thus causing an earlier appearance and an
increase in the severity of clinical manifestation in successive
generations, where greater the number of repeats occur along
the gene, the more severe are the clinical manifestations of
the disease This pathogenetic mechanism underlies the phe-
nomenon of genetic anticipation. Anticipation disorders fre-
quently involve repeating or expansion of three adjacent
nucleotides (triplet repeat expansion). A long, ever expanding,
list of genetic disorders caused by this nucleotide repeat expan-
sion pathogenetic mechanism is delineated, most of them are
due to the expansion of adjacent triplets, three nucleotides,
hence referred to as triplet repeat expansion diseases. These
disorders have widely varying clinical phenotypes depending
on many factors including the specific nucleotide repeat, the
412 M.S.Z. Salemsize of the repeat expansion and the functional role(s) of the
gene product(s).
In over half of these disorders, the repeated codon or trip-
let, CAG (Cytosine-Adenine-Guanine), codes for glutamine
amino acid resulting in the synthesis of a polyglutamine seg-
ment, or tract, in the resulting protein. These diseases are com-
monly referred to as polyglutamine diseases. In the remaining
disorders, the repeated codons do not code for glutamine
and are classified as non-polyglutamine diseases (Tables 3 & 4).
4. Mitochondrial inheritance
The exclusive presence of mitochondria in the ovum, but not in
the sperm, imparts to genetic diseases caused by mutations of
mitochondrial genes specific non-mendelian inheritance pat-
terns. Furthermore, oxidative-phosphorylation networks
responsible for the ATP production in the mitochondria are
mediated by proteins and enzymes synthesized by both mito-
chondrial and nuclear genes. Due to the maternal origin of
mitDNA, mitochondrial mutations/disorders are inherited
from the mother. In mitochondrial inheritance, a woman
who carries a mutant mitochondrial gene passes the mutant
gene to all her offspring and her daughters will pass the
mutated mitochondria to their children. However, her sons
will not transmit the disease to any of their children becauseTable 3 Polyglutamine (CAG) triplet repeat expansion diseases.
Disease Muta
HD (Huntington’s disease) HTT




SCA1 (Spinocerebellar ataxia Type 1) ATX
SCA2 (Spinocerebellar ataxia Type 2) ATX
SCA3 (Spinocerebellar ataxia Type 3 or
Machado–Joseph disease)
ATX
SCA6 (Spinocerebellar ataxia Type 6) CAC
SCA7 (Spinocerebellar ataxia Type 7) ATX




Table 4 Non-Polyglutamine triplet repeat expansion diseases.
Disease Mutant gene




FMR1, on the X-
chromosome
DM (myotonic dystrophy) DMPK
FRDA (Friedreich’s ataxia) FXN or X25, (fra
reduced expressio









PPP2R2B or SCAsperm mitochondria do not participate in fertilization and
zygote formation. Examples of genetic diseases manifesting
this specific inheritance pattern because of mitochondrial gene
mutations include Leber’s hereditary optic neuropathy
(LHON), the Wolff-Parkinson-White syndrome, Neuropathy,
ataxia, retinitis pigmentosa, and ptosis (NARP), Leigh’s neu-
ropathy-encephalopathy syndrome, the Myoclonic Epilepsy
and Ragged Red Fibers syndrome (MERRF), Mitochondrial
myopathy, encephalomyopathy, lactic acidosis, stroke-like
symptoms (MELAS), mitochondrial neurogastrointestinal
encephalomyopathy (MNGIE), Diabetes mellitus and deafness
(DAD), the Kearns–Sayre syndrome (KSS), the Pearson syn-
drome and many others.
Mutations in mitochondrial genes can be diagnosed by the
molecular mutation analysis of mitochondrial gene. The list of
mitochondrial diseases is progressively increasing and com-
prises endless numbers of genetic defects/disorders due to the
central roles mediated by the mitochondria in ATP and energy
production in the cell. Additionally, mitochondria conduct
many other critical metabolic and regulatory roles in the cell
including mediation and regulation of urea cycle reactions,
regulation of apoptosis, cell aging, fatty acid metabolism, gly-
colysis pathways in stressful condition, storage of calcium ions
and regulation of calcium homeostasis, synthesis of heme, syn-
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Table 5 Multifactorial or complex disorders.
Congenital malformations: cleft palate/lip, neural tube defects such
as spina bifida
Cardiovascular diseases: high blood pressure, some causes of heart
disease, high cholesterol
Neurological/psychiatric disorders: Alzheimer disease in later life,
schizophrenia, bipolar disorder
Skin disorders: psoriasis, moles, eczema
Respiratory: asthma, allergies, emphysema
Muscular/skeletal diseases: arthritis, rheumatic disorders,
osteoporosis
Metabolic disorders: diabetes
Malignant tumors: bowel, breast, ovarian, bowel, melanoma and
prostate
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Multifactorial, or complex, genetic disorders are caused by
combined actions of both an environmental factor and a
genetic component. Pathogenesis of multifactorial diseases is
attributed to the deleterious actions exerted by the environ-
mental factor on the susceptible genetic background. The spec-
trum of these diseases is very wide in the view of the countless
numbers of environmental factors capable of damaging the
genetic constitution of humans, mutagens/teratogens/carcino-
gens/clastogens, and the exceedingly large numbers of mutant
genes that make their bearers at a high susceptibility risk of
suffering diseases upon exposure to an offending environmen-
tal trigger. The impact of the genetic susceptibility to environ-
mental factors varies widely as regards its nature, sex of
susceptible individual and magnitude of the genetic deviation
from normal status. The nature of the genetic deviation deter-
mines to a large extent the susceptibility to and the possibility
of developing a multifactorial disease [5].
In view of the very early exposure of the zygote and descen-
dant cells to multitudes of intra-uterine and extra-uterine envi-
ronmental effectors that persists all through stages of
embryonic and fetal development till birth, and get intensified
all through post-natal life till death. Accordingly, multifacto-
rial diseases can develop during intra-uterine development in
view of embryonic/fetal susceptibility to deleterious effects of
mutagenic factors, particularly teratogenic mutagens, where
they make their appearance and present as congenital multifac-
torial diseases, e.g. congenital malformations. Alternatively,
multifactorial diseases can develop at any time during post-
natal life as the consequences of somatic mutations imposed
by the persistent and everlasting every day exposure of human
cells to the environmental mutagens, viz. carcinogens/ clasto-
gens/non-specific mutagens, present everywhere in our envi-
ronment. Common examples of acquired multifactorial
diseases include non-hereditary cancers, immunodeficiency dis-
orders, coronary heart disease, hypertension, diabetes mellitus,
schizophrenia, peptic ulcer disease, tuberculosis, psoriasis and
many others.
Genetic deviations comprising subtle defects in DNA repair
mechanisms or mild incompetence of the immune system are
expected to progress to drastic pathological conditions, e.g.,
cancer and immunodeficiency, upon being sufficiently stressed
by potent environmental mutagens, than other genetic devia-
tions involving less important or non-critical aspects of genetic
functions. For these reasons, multi-factorial disorders vary
widely as regards their rates of occurrence, sex predilection,
ethnic distribution, age of onset, phenotypic spectrum and
prognostic outcomes. However, the mere presence of suscepti-
ble individual genetic constitution does not dictate indispens-
able development of the disease unless pathogenetic exposure
of specific targeted cells to the effects of the proper mutagen
in a sufficient dose at a critical time occurs.
Neither the exact pathogenetic mechanisms nor the nature
of the genetic component in multifactorial diseases are com-
pletely understood. Though a polygenic component has been
postulated to be responsible for conferring genetic susceptibil-
ity in these diseases, none of the complete sets of genes related
to specific complex multifactorial diseases have been defined.
Accordingly, screening, early diagnosis or prophylactic
approaches are not available for the majority of these diseases.The estimation of the occurrence or recurrence risk for devel-
oping a specific multifactorial disease in a particular family is
largely speculative and is dependent on many factors includ-
ing: sex of the index case, age at onset of clinical manifesta-
tions and the clinical course of the disease, closeness to
affected individuals, number of affected cases in the family,
ethnic background and many others. Provisional diagnosis of
suspected multifactorial diseases rests on many clues that
include undefined complex clinical phenotypes affecting many
family members and transmitted in a pattern that do not con-
form with known rules of Mendelian inheritance. Failure to
detect molecular/cytogenetic/biochemical abnormalities is an
additional clue to suspect the multifactorial background of
these diseases (Table 5).
6. Mosaicism
Mosaicism signifies the presence of two or more populations of
cells with different genetic constitutions, or genotypes, of each
in an individual who has developed from a single zygote. Var-
ious mechanisms underlie the development of this abnormal
genetic condition. In the preimplantation embryonic stage,
anaphase lag appears to be the main process by which mosai-
cism arises. Chromosomal non-disjunction and whole genome
endoreduplication are other pathogenetic mechanisms that can
lead to mosaicism. Post-fertilization mutational events propa-
gated to a subset of descendant cells results in the mosaicism of
varying tissues or parts of organs that develop from these cells
in later stages of development. For instance, mosaic children
with the Down syndrome have two cell lines, one normal with
46 chromosomes and another triploid cell population having
47 chromosomes. Also, about 50% of cases with the turner
syndrome have mosaic genetic constitution with a portion of
normal cells (46,XX) and a portion of X-monosomic cells
(45,X). Due to the presence of a normal cell line, individuals
with mosaicism usually tend to have milder clinical pheno-
types, or clinical manifestations compared to individuals
having only classic abnormal cell lines, i.e., whole trisomic
Down syndrome patients. Variations in clinical phenotypes
in mosaicism depend on the relative distribution of normal/
abnormal cells in different tissues and organs, as well as on
the physiological importance of affected organs in mediating
body functions [6].
Mosaicism might be somatic, occurring in somatic cells, or
germinal occurring in germline cells, i.e. sperms and ova. Also,
414 M.S.Z. Salemit might be chromosomal mosaicism, with a cell line having an
extra chromosome, or single gene mosaicism when one of the
cell lines having a mutant gene present in all cells of this abnor-
mal cell line. Typically, somatic mosaicism is not passed to
future generations. However, somatic mosaicism with a popu-
lation of cells having a mutant gene can cause pathological
consequences like carcinogenesis. If a mutation happens in
germline mosaicism, a population of germ cells having the
mutation might result leading to the transmission of the disor-
der to future generations. Germline or gonadal mosaicism for
mutations of genes causing autosomal dominant or X-linked
disorders often accounts for unexpected occurrence and recur-
rence of the disorder in offspring of phenotypically normal
parents. Genetic disorders known to be caused by this abnor-
mal inheritance mechanism, in addition to the classic Mende-
lian pattern of inheritance, include Duchenne muscular
dystrophy, osteogenesis imperfecta (brittle bone disease) and
neurofibromatosis type I. germinal mosaicism has to be con-
sidered in families with many affected offspring with well-
defined single gene molecular or cytogenetic defects which can-
not be revealed in either of their parents.
7. Chromosomal aberrations
Chromosomal abnormalities comprise many different types
which can involve a whole chromosome or just a segment of
a chromosome. In either situation, the abnormalities may
affect chromosome numbers, numerical chromosomal aberra-
tions, or chromosome structure, structural chromosomal
abnormalities. Numerical whole chromosomal aberrations
include X-monosomy (45,X)/X-trisomy (47,XXX)/X-tetra-
somy (48,XXXX) and many different autosomal trisomies,
e.g. 13, 18 and 21 trisomy. Multiple numerical abnormalities
of chromosomes include exceptional cases of hypodiploidy
and hyperdiploidy seen only in malignant cells. Abnormalities
of the whole haploid set of chromosomes can lead to rare cyto-
genetic defects like triploidy (69 chromosomes) and tetraploidy
(92 chromosomes). Endoreduplication refers to the situation
where replication of DNA leading to the duplication of chro-
mosome number happens without concomitant cell division
thus resulting in a cell with two diploid (92) genomes. This
condition is occasionally observed in rapidly growing and
dividing cells, like hepatocytes and bone marrow cells. Struc-
tural chromosomal aberrations comprise a wide spectrum of
abnormalities including translocations, inversions, deletions,
duplications, ring chromosome formation, isochromosome
formation, chromosome breakage and many others [7].
Most instances of chromosomal abnormalities happen as
random events during the formation of reproductive cells or
in early fetal development. Obviously, chromosomal disorders
do not conform with Mendelian patterns of inheritance. How-
ever, recurrence of a structural chromosomal anomaly in off-
spring of a parent who carries a constitutional chromosomal
aberration might happen. Due to the recombination of chro-
mosomal segments during gametogenesis, different gametes
of a person carrying a constitutional structural abnormality
might get the defective segments albeit with different genetic
constitutions of each. Occurrence of offspring with varying
clinical phenotypes suggestive of a chromosomal disorder in
a family with phenotypically normal parents should raise the
suspicion of carrying a chromosomal rearrangement whichcan be detected by cytogenetic diagnostic techniques. Prenatal
cytogenetic studies of all future pregnancies should be per-
formed in these situations.
8. Microdeletion/microduplication/microtriplication defects
These tiny peculiar defects represent submicroscopic structural
chromosomal abnormalities that cannot be detected by ordin-
ary cytogenetic investigation, rather they are amenable to diag-
nosis by molecular cytogenetic techniques like Fluorescence
in situ hybridization (FISH). In view of the large numbers of
genes distributed and located on functional regions of the
chromosomes, even tiny defects of chromosomes like microde-
letion/microduplication/microtriplication can involve consid-
erably large numbers of gene in affected segments. Because
of concomitant participation of many contiguous genes of
these segments in formulating the clinical phenotypes caused
by these defects, contiguous gene disorders with variable,
sometimes, wide spectrum of clinical manifestations are
observed. For example, some patients with Cri-du-Chat, or
cat cry, syndrome may have the deletion of the entire micro
segment on the short arm of chromosome 5 (5p). However,
the essential region underlying the pathognomonic clinical
phenotype of the disorder involves genes located in the critical
region 5p15.2. The high pitched cry gene maps to 5p15.3 while
genes accounting for the remaining features map to a small
region of 5p15.2. It is estimated that about 100 genes reside
in this region. Deletions that do not include these critical genes
located in 5p15.2/15.3 present varying clinical phenotypes
ranging from microcephaly, facial dysmorphism, severe mental
retardation and multiple congenital anomalies to essentially
clinically normal phenotype.
Because of the common occurrence of microdeletion/micro-
duplication/microtriplication regions along many chromo-
somes and at the telomeres, the number of disease
phenotypes attributed to this abnormal pathogenetic mecha-
nism is steadily increasing. Examples of these diseases include
the William syndrome, DiGeorge syndrome, velocardiofacial
anomaly, Shprintzen syndrome, Miller–Dieker lissencephaly
syndrome, Wolf–Hirschhorn syndrome, Cri du Chat syn-
drome, Smith–Magenis syndrome, Langer–Giedion syndrome,
Saethre–Chotzen syndrome and retinoblastoma. Also, cases of
many diseases caused by different pathogenetic mechanisms,
e.g., the Prader–Willi/Angelman syndromes and the Beck-
with–Wiedemann syndrome caused by defective imprinting/
uniparental disomy, are also caused by this peculiar cytoge-
netic defect.
9. Polygenic defects
Polygenic defects refer to genetic disorders caused by the com-
bined effects of many mutant genes. This pathogenetic mecha-
nism underlies the development of a considerable number of
congenital malformations because normal differentiation,
development and growth of embryonic and fetal tissues and
organs require the additive functions of large numbers of genes.
Polygenic defects are postulated to represent the commonest
genetic component in multifactorial diseases. Examples of mul-
tifactorial diseases with a polygenic genetic background include
complex congenital malformations of the heart and the nervous
system, non-insulin dependent type of diabetes mellitus,
Basic concepts of medical genetics 415obesity, allergic and autoimmune disorders, hypertension,
inflammatory bowel disease and intellectual disability [8]. Can-
cer represents a drastic example of genetic disorders caused by
disturbed polygenic effects of many tumor-promoting and
tumor suppressor genes. The polygenic background in carcino-
genesis might be purely genetic or it might represent the genetic
component in tumors caused by multifactorial pathogenetic
mechanisms. The environmental effectors in these pathogenetic
mechanisms include carcinogens that selectively promote func-
tional overexpression of proto-oncogenes with or without con-
comitant suppression of tumor suppressor genes, clastogens
that induce chromosome breaks and instability leading to dis-
ruption of the structural integrity of tumor suppressor genes
or to chromosomal translocations/rearrangements leading to
overexpression of proto-oncogenes and non-specific mutagens
capable of inducing similar defects.
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